Cargando…

Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes

The International Parkinson’s and Movement Disorder Society (MDS) criteria for progressive supranuclear palsy (PSP) have broadened the clinical spectrum of the disease and established phenotypic characterization according to the predominant manifestation at onset. The objective of this study is to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Campagnolo, Marta, Weis, Luca, Fogliano, Carmelo, Cianci, Valeria, Garon, Michela, Fiorenzato, Eleonora, Carecchio, Miryam, Ferreri, Florinda, Bisiacchi, Patrizia, Antonini, Angelo, Biundo, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902314/
https://www.ncbi.nlm.nih.gov/pubmed/36701008
http://dx.doi.org/10.1007/s00702-023-02591-z
_version_ 1784883232667336704
author Campagnolo, Marta
Weis, Luca
Fogliano, Carmelo
Cianci, Valeria
Garon, Michela
Fiorenzato, Eleonora
Carecchio, Miryam
Ferreri, Florinda
Bisiacchi, Patrizia
Antonini, Angelo
Biundo, Roberta
author_facet Campagnolo, Marta
Weis, Luca
Fogliano, Carmelo
Cianci, Valeria
Garon, Michela
Fiorenzato, Eleonora
Carecchio, Miryam
Ferreri, Florinda
Bisiacchi, Patrizia
Antonini, Angelo
Biundo, Roberta
author_sort Campagnolo, Marta
collection PubMed
description The International Parkinson’s and Movement Disorder Society (MDS) criteria for progressive supranuclear palsy (PSP) have broadened the clinical spectrum of the disease and established phenotypic characterization according to the predominant manifestation at onset. The objective of this study is to describe clinical/cognitive and imaging features of a monocentric cohort of PSP patients, highlighting different patterns of functional disability according to the assigned phenotype. We retrospectively reviewed clinical/imaging data of 53 PSP patients diagnosed with probable PSP according to the MDS criteria and 40 age/sex-matched healthy controls (HCs). Neurological/neuropsychological assessments were performed using standardized scales, as well as comprehensive magnetic resonance imaging (MRI) morphometric measurements. In our cohort, there were 24/53 PSP-RS (Richardson’s syndrome), 13/53 PSP-P (Parkinsonism), 7/53 PSP-PGF (Progressive gait freezing), and 9/53 PSP-Cog (Cognitive impairment). PSP-Cog presented the worst motor profiles, the highest percentages of dementia and impaired functional autonomy; 4/9 PSP-Cog and 2/7 PSP-PGF died. PSP-P had the lowest motor/cognitive burden. All MRI parameters had good discriminative efficacy vs. HCs, with P/M 2.0 discriminating PSP-PGF from PSP-RS and PSP-Cog. We highlighted discrete clinical and imaging patterns that best characterize different PSP phenotypes. PSP-Cog and PSP-PGF/RS manifest greater incidence of dementia and motor disability, respectively, while PSP-P has a more benign course. The identification of different phenotypes may be the expression of different progression patterns requiring tailored approaches in terms of follow-up and treatment. These findings support the concept of discrete patterns of Tau pathology within the PSP spectrum and encourage research for phenotype-specific outcome measures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00702-023-02591-z.
format Online
Article
Text
id pubmed-9902314
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-99023142023-02-08 Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes Campagnolo, Marta Weis, Luca Fogliano, Carmelo Cianci, Valeria Garon, Michela Fiorenzato, Eleonora Carecchio, Miryam Ferreri, Florinda Bisiacchi, Patrizia Antonini, Angelo Biundo, Roberta J Neural Transm (Vienna) Neurology and Preclinical Neurological Studies - Original Article The International Parkinson’s and Movement Disorder Society (MDS) criteria for progressive supranuclear palsy (PSP) have broadened the clinical spectrum of the disease and established phenotypic characterization according to the predominant manifestation at onset. The objective of this study is to describe clinical/cognitive and imaging features of a monocentric cohort of PSP patients, highlighting different patterns of functional disability according to the assigned phenotype. We retrospectively reviewed clinical/imaging data of 53 PSP patients diagnosed with probable PSP according to the MDS criteria and 40 age/sex-matched healthy controls (HCs). Neurological/neuropsychological assessments were performed using standardized scales, as well as comprehensive magnetic resonance imaging (MRI) morphometric measurements. In our cohort, there were 24/53 PSP-RS (Richardson’s syndrome), 13/53 PSP-P (Parkinsonism), 7/53 PSP-PGF (Progressive gait freezing), and 9/53 PSP-Cog (Cognitive impairment). PSP-Cog presented the worst motor profiles, the highest percentages of dementia and impaired functional autonomy; 4/9 PSP-Cog and 2/7 PSP-PGF died. PSP-P had the lowest motor/cognitive burden. All MRI parameters had good discriminative efficacy vs. HCs, with P/M 2.0 discriminating PSP-PGF from PSP-RS and PSP-Cog. We highlighted discrete clinical and imaging patterns that best characterize different PSP phenotypes. PSP-Cog and PSP-PGF/RS manifest greater incidence of dementia and motor disability, respectively, while PSP-P has a more benign course. The identification of different phenotypes may be the expression of different progression patterns requiring tailored approaches in terms of follow-up and treatment. These findings support the concept of discrete patterns of Tau pathology within the PSP spectrum and encourage research for phenotype-specific outcome measures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00702-023-02591-z. Springer Vienna 2023-01-26 2023 /pmc/articles/PMC9902314/ /pubmed/36701008 http://dx.doi.org/10.1007/s00702-023-02591-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Neurology and Preclinical Neurological Studies - Original Article
Campagnolo, Marta
Weis, Luca
Fogliano, Carmelo
Cianci, Valeria
Garon, Michela
Fiorenzato, Eleonora
Carecchio, Miryam
Ferreri, Florinda
Bisiacchi, Patrizia
Antonini, Angelo
Biundo, Roberta
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
title Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
title_full Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
title_fullStr Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
title_full_unstemmed Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
title_short Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
title_sort clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
topic Neurology and Preclinical Neurological Studies - Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902314/
https://www.ncbi.nlm.nih.gov/pubmed/36701008
http://dx.doi.org/10.1007/s00702-023-02591-z
work_keys_str_mv AT campagnolomarta clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes
AT weisluca clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes
AT foglianocarmelo clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes
AT ciancivaleria clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes
AT garonmichela clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes
AT fiorenzatoeleonora clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes
AT carecchiomiryam clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes
AT ferreriflorinda clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes
AT bisiacchipatrizia clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes
AT antoniniangelo clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes
AT biundoroberta clinicalcognitiveandmorphometricprofilesofprogressivesupranuclearpalsyphenotypes